Moreover, anti-MIF neutralizing antibodies, MIF-directed RNA silencing, or small molecule MIF inhibitors have been tested in vitro and in preclinical tumor models with notable responses, but studies into the mechanisms of activity remain limited (27–29). Here, MIF is linked to neoplasm.